SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-19-039500
Filing Date
2019-02-14
Accepted
2019-02-14 09:03:32
Documents
1
Group Members
PROSIGHT FUND, LPPROSIGHT PARTNERS, LLCPROSIGHT PLUS FUND, LPW. LAWRENCE HAWKINS

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d672782dsc13ga.htm SC 13G/A 106003
  Complete submission text file 0001193125-19-039500.txt   107728
Mailing Address 301 NORTH MAIN STREET, SUITE 100 ANN ARBOR MI 48104
Business Address 301 NORTH MAIN STREET, SUITE 100 ANN ARBOR MI 48104 734-845-9000
Millendo Therapeutics, Inc. (Subject) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87213 | Film No.: 19601289
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2301 CEDAR SPRINGS ROAD, SUITE 355 DALLAS TX 75201
Business Address 2301 CEDAR SPRINGS ROAD, SUITE 355 DALLAS TX 75201 214-468-0008
Prosight Management, LP (Filed by) CIK: 0001617201 (see all company filings)

IRS No.: 263706721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A